The newest addition to the team: Joseph Lim

Joseph Lim is the newest addition to our laboratory. He is a part of the international Ph.D. program, V.A. Cure, which studies the molecular basis of vascular anomalies. Joseph graduated with the highest distinction from Nanyang Technological University, Singapore, in 2019. His prior work on topics, such as tissue engineering and tumor hypoxia, allowed him to gain first insights into the role of endothelial cells in various pathologies. For his Ph.D. project, Joseph aims to study the role and therapeutic potential of endothelial metabolic adaptions in vascular malformations. Click on the following link to get more information on the V.A. Cure network.